# Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation

Study · id `cardio:ct-nct02234102` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02234102](<https://clinicaltrials.gov/study/NCT02234102>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02234102

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT02234102. Non-randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT02234102, source copy `cardio:ctgov-nct02234102-2015-08-21`, retrieved 2026-10-26)
- Start date: 2014-08 (registry gives no type) (ClinicalTrials.gov record NCT02234102, source copy `cardio:ctgov-nct02234102-2015-08-21`, retrieved 2026-10-26)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02234102, source copy `cardio:ctgov-nct02234102-2015-08-21`, retrieved 2026-10-26)
- Completion: 2017-06 (anticipated) (ClinicalTrials.gov record NCT02234102, source copy `cardio:ctgov-nct02234102-2015-08-21`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT02234102, source copy `cardio:ctgov-nct02234102-2015-08-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02234102-2015-08-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Eagle AF (Atrial Fibrillation) - Endoscopically Guided Laser Ablation of Persistent Atrial Fibrillation
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): Endoscopically guided laser ablation HeartLight system
- Lead sponsor: Prof. Dr. med. Bernd Lemke
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 5dac0c9a0fb9769de0219990a5da5a9c0868821f500bbd95de503dc4b5d6552e
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
